ISZO Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

ISZO Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-582,409	Closed	-$90M	–	10
2015 Q4	$90M	Sell	582,409 -177,511	-23%	-$25.9M	60.33%	1
2015 Q3	$109M	Sell	759,920 -117,164	-13%	-$16.4M	61.63%	1
2015 Q2	$126M	Sell	877,084 -133,643	-13%	-$19.1M	65.2%	1
2015 Q1	$143M	Sell	1,010,727 -84,548	-8%	-$13M	69.68%	1
2014 Q4	$162M	Sell	1,095,275 -3,100	-0.3%	-$456K	75.59%	1
2014 Q3	$169M	Sell	1,098,375 -5,793	-0.5%	-$872K	85.7%	1
2014 Q2	$155M	Sell	1,104,168 -40	-0%	-$4.44K	80.27%	1
2014 Q1	$123M	Buy	+1,104,208	New	+$120M	73.74%	1

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ISZO Capital Management's TARO Position: Q1 2016 in Review

ISZO Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2016, closing a stake of 582,409 shares — an estimated $90M sold.

ISZO Capital Management first reported a position in TARO in Q1 2014 and held it in 8 quarters. The position peaked at $169M in Q3 2014. 167 funds tracked by Wall St. Rank hold TARO as of Q1 2016.

ISZO Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2016 after selling out during the quarter.
ISZO Capital Management sold 582,409 Taro Pharmaceutical Industries Ltd. shares in Q1 2016, an estimated $90M.
ISZO Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 8 quarters.
ISZO Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $169M in Q3 2014.
167 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2016.

Based on ISZO Capital Management's 13F filing for Q1 2016, filed 16 May 2016.